Patients diagnosed with mCRPC displayed 2–3 times higher levels of CgA and NSE compared to those with localized PCa, according to an examination of 1095 serum samples from 395 men, including 157 with localized PCa and 238 with mCRPC [105]. This evidence concerns the gene CGA and posterior cortical atrophy.